|
Miricorilant Clinical Trials
2 actively recruiting trials across 2 locations
▲ +1 trial since May 2026
Pipeline
Phase 1: 2
Top Sponsors
- Corcept Therapeutics2
Indications
- Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)2
- Nonalcoholic Steatohepatitis (NASH)2
- Liver Disease2
- Non-alcoholic Fatty Liver Disease NAFLD2
- Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis1
Columbia, Missouri1 trial
Evaluation of Miricorilant on Liver Fat in Patients With MASLD
University of Missouri
Phase 1
San Antonio, Texas1 trial
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.